ARCHIVES

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

This article is from The Cancer Letter archive.

Vol. 40 No. 32 | August 8, 2014

Download PDF Visit The Full Archive

Related Articles

How Construction Grantees Will Spend Their $30 Million

September 12, 1975

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

New Publications

January 20, 1989

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

January 25, 2008

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Sept. Is AMA’s Month of Women In Medicine

September 10, 1993